OR WAIT null SECS
© 2022 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.
© 2022 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
A panel of experts in ophthalmology and optometry review the diagnosis and treatment of diabetic eye disease including emerging agents in the field.
December 1st 2020
Expert optometrists and ophthalmologists provide an overview of diabetic retinopathy and the standard of care for a diabetes eye exam.
The importance of imaging in a diabetes eye exam with OCT-A and widefield angiograms is examined.
Evaluating the use of OCT-A for patients with diabetes in clinical practice and whether it should become a standard of care.
A discussion on educating a patient with diabetes on disease management, including routine hemoglobin A1C screenings to optimize health, and sending a referral to a retina specialist.
Experts discuss successful communication among optometrists, retina specialists, and primary care providers when treating a patient with diabetes.
Approaching the practical management of proliferative and nonproliferative diabetic retinopathy (DR) and diabetic macular edema (DME) according to the ADA (American Diabetes Association) guidelines.
The role of DRCR.net clinical trials in guiding the management of DR/DME and a review of the safety and efficacy of anti-VEGF agents.
Challenges commonly faced by providers for the treatment of diabetes and how to ensure patients come back for follow-up visits.
Emerging agents and therapies in the pipeline for the treatment of diabetic retinopathy and diabetic macular edema.